Regulation Awareness and Experience of Additional Monitoring among Healthcare Professionals in Finland
Background: Challenges in post-marketing adverse event reporting are generally recognized. To enhance reporting, the concept of additional monitoring was introduced in 2012. Additional monitoring aims to enhance reporting of adverse events (AE) for medicines for which the clinical evidence base is l...
Guardado en:
Autores principales: | Andreas Sandberg, Pauliina Ehlers, Saku Torvinen, Heli Sandberg, Mia Sivén |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b70d43ce107a4bfaad0e36f9b0ba96da |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Spontaneous reporting of adverse drug reactions: nurses’ perception
por: Erefai Ouassima, et al.
Publicado: (2021) -
Farmacovigilancia activa de metoclopramida 10 mg oral en pacientes del Programa de Alivio del Dolor y Cuidados Paliativos o diabetes mellitus tipo 2 en cinco hospitales del Servicio de Salud Viña del Mar-Quillota
por: Frez,Carla, et al.
Publicado: (2018) -
Using Population-Based Structures to Actively Monitor AEFIs during a Mass Immunization Campaign—A Case of Measles–Rubella and Polio Vaccines
por: Dan Kajungu, et al.
Publicado: (2021) -
A 5 year retrospective analysis of adverse drug reactions associated with antimicrobials in a teaching hospital of Andaman and Nicobar islands
por: Mangesh Bankar, et al.
Publicado: (2021) -
Quality assessment of individual case safety reports in pharmacovigilance in Burkina Faso
por: Roamba Nazaire, et al.
Publicado: (2021)